TDTolga Meriç Dümbek

Tolga Meriç Dümbek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tolga Meriç Dümbek has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum Intercellular Adhesion Molecule-1 Levels Following Dental Follicle-Derived Mesenchymal Stem Cell and Microfracture Treatments in a Rabbit Osteochondral Defect Model

    by İhsan Yağcı, Deniz Genç, Umut Canbek, Osman Bulut, Leyla Tekin, Elif Vargün, Çiğdem Elif Akgün, Funda Dinç, Tolga Meriç Dümbek, Ali Batuhan Bayırlı, et al.

    This study aimed to compare serum intercellular adhesion molecule-1 (ICAM-1) levels following human dental follicle-derived mesenchymal stem cell and microfracture treatments in a rabbit model of osteochondral cartilage damage. Female New Zealand rabbits aged 2–3 months and weighing approximately 2.5 kg were used in the study. The animals were divided into three groups: an untreated defect control group, a group treated with 5 × 10⁶ lyophilized human dental follicle-derived mesenchymal stem cells applied to the defect area (xenogeneic application), and a group in which five microfracture holes were created at the base of the defect. At 16 weeks postoperatively, serum ICAM-1 levels were measured in a total of 16 serum samples, including four animals in the defect control group, six animals in the mesenchymal stem cell group, and six animals in the microfracture group, using a sandwich ELISA assay. A significant difference was found among groups in serum ICAM-1 levels (P < 0.001). The highest serum ICAM-1 level was detected in the defect control group (262.28 ± 20.59 ng/L), while the lowest level was found in the mesenchymal stem cell group (142.29 ± 3.91 ng/L). In the microfracture group, the value was 210.15 ± 24.19 ng/L. These findings suggest that dental follicle-derived mesenchymal stem cell treatment was associated with lower terminal serum ICAM-1 levels than microfracture treatment or untreated defects. However, serum ICAM-1 is not cartilage-specific, and further studies are needed to clarify the biological significance of these findings.

  • Open Access

    Feline Chronic Gingivostomatitis

    by Tolga Meriç Dümbek, Tolga Meriç, Osman Bulut

    Feline chronic gingivostomatitis (FCGS) is a chronic, painful inflammatory disease of the feline oral mucosa that can severely impair quality of life and, in some cases, lead to euthanasia. The disease is distinguished from gingivitis and periodontal disease by inflammation extending beyond the mucogingival junction into the buccal and caudal oral mucosa. Reported prevalence varies widely depending on the population studied and the case definition used, and multi-cat households are consistently associated with increased risk. The etiopathogenesis is multifactorial and incompletely understood; feline calicivirus and other viral agents, oral microbiome dysbiosis and profound local and systemic immune dysregulation, including T-cell exhaustion, are thought to contribute. Clinical signs include oral pain, dysphagia, ptyalism, halitosis, anorexia, weight loss and reduced grooming, with edematous, proliferative or ulcerated lesions that bleed easily. Diagnosis relies on the criteria proposed by Healey et al. (2007) and on histopathological confirmation, which is also essential to exclude mimicking conditions, particularly oral squamous cell carcinoma. Transcriptomic biomarkers are emerging as promising diagnostic tools. Treatment follows a stepwise approach: tooth extraction as first-line therapy, medical immunomodulation with cyclosporine and interferon-omega in refractory cases, and mesenchymal stromal cell therapy as a regenerative option. Approximately two-thirds of cats achieve remission or marked improvement after extraction, whereas up to 30% remain refractory. This chapter reviews the terminology, epidemiology, etiopathogenesis, clinical findings, diagnosis, treatment and prognosis of FCGS, and highlights current knowledge gaps and future research directions.

  • Open Access

    Ocular Ultrasonography in Cats and Dogs

    by Osman Bulut, Tolga Meriç Dümbek

    Ocular ultrasonography (OU) is a non-invasive, real-time imaging technique that allows evaluation of intraocular, orbital and retrobulbar structures in dogs and cats, particularly when opaque ocular media such as corneal edema, hyphema or cataract preclude ophthalmoscopic examination. In most patients, it can be performed in conscious animals under topical anesthesia without sedation. This chapter reviews the relevant ocular and orbital anatomy, indications and contraindications, equipment selection, patient preparation and scanning techniques, including the transcorneal and transpalpebral approaches. The normal B-mode and A-mode appearance of the globe is described, together with biometric measurement landmarks and factors influencing ocular dimensions, such as body weight, skull conformation and species. Pathological findings are presented according to anatomical location, including anterior segment lesions, cataract and lens luxation, vitreous hemorrhage and degeneration, retinal and choroidal detachment, intraocular neoplasia, glaucoma, uveitis, orbital and retrobulbar disease, and ocular trauma with foreign bodies. Common technical artifacts and criteria for differentiating retinal detachment from other intravitreal membranes are also discussed. Interspecies differences are emphasized, such as the deeper anterior chamber and wider iridocorneal angle of cats, and conditions such as feline post-traumatic ocular sarcoma. Although highly operator-dependent, OU remains an accessible and valuable first-line diagnostic tool when combined with appropriate transducer selection, gain optimization and bilateral comparison. Ultrasound biomicroscopy, Doppler and contrast-enhanced ultrasonography, as well as computed tomography and magnetic resonance imaging, provide complementary information in selected cases.

  • Open Access

    Effects of platelet-rich fibrin on experimentally induced corneal wounds in rats

    by Tolga Meriç Dümbek, Doğan Can Haney, Osman Bulut, Ayşe Nur Akkoç, Gökçe Kayğusuz

    Background: Platelet-rich fibrin (PRF) is an autologous biomaterial rich in growth factors that can support tissue regeneration. Its effects on corneal wound healing, particularly in terms of shape and thickness, remain unclear. Aim: This study aimed to evaluate the healing efficacy of PRF in experimentally created corneal wounds in rats using morphological, histological, and immunological assessments. Methods: Fifty-four male Wistar albino rats were divided into three groups after corneal defects: 2 mm PRF + tarsorrhaphy, 5 mm PRF + tarsorrhaphy and sham (tarsorrhaphy only). PRF was applied in free form. Wound closure was measured at 24, 48, and 72 h using fluorescent staining. Histopathology and cytokines (EGF, TNF- α , IL-6, IL-10) were evaluated. Results: Wound areas decreased in all groups, and there was no significant difference between PRF and control corneas ( p > 0.05). EGF increased at 24 h in the 2 mm group and remained high up to 72 h. TNF- α and IL-6 were higher in the 5 mm group at 48–72 h, while IL-10 increased with PRF thickness but did not suppress inflammation. Histopathological examination showed that epithelial regeneration was almost complete in the control corneas, while stromal edema, inflammatory infiltration, and neovascularization were observed in the PRF-treated corneas, especially in the 5 mm group. Conclusion: Free-form PRF did not increase epithelial closure in rat corneal wounds and triggered a thickness-dependent inflammatory response; this indicates that PRF thickness must be carefully evaluated in ocular applications.

  • Open Access

    Emergency and Critical Care Management in Exotic Animals

    by Zeynep Bozkan Ünal, Tolga Meriç Dümbek

    Exotic animal emergency and critical care management requires knowledge and experience on species-specific anatomical, physiological, and behavioural differences. While most exotic pets hide their clinical signs until advanced stages of illness, careful observation and appropriate intervention are essential to improve treatment outcomes when the animal is first presented. Stabilization of the patient is based on the correction of hypothermia and dehydration, reduction of stress, and the provision of oxygen and nutritional support, with pain management and drug administration adjusted to the species. When cardiopulmonary resuscitation (CPR) is required, differences in airway anatomy, respiratory rate, heart position, and metabolic requirements among exotic species should be taken into consideration. Drug administration, such as vasopressors, parasympatholytic agents, or glucose during CPR, should be organized based on the metabolic and enzymatic characteristics of the animal species. Monitoring of ECG, end-tidal CO₂, and body temperature is essential, especially in reptiles, because of the limited applicability of auscultation. Early diagnosis, appropriate stabilization, and an evidence-based therapeutic approach are crucial to improving the survival rate and quality of life in exotic pet patients.

  • Investigation of the efficacy of intra-articular botulinum toxin type A application in the treatment of experimentally induced osteoarthritis in rats

    by Tolga Meriç Dümbek, Zeynep Bozkan Ünal

    This study aimed to evaluate the effectiveness of botulinum toxin type A in rat model of experimentally induced osteoarthritis. The experiment was conducted on 30 male Sprague-Dawley rats. Osteoarthritis was induced via intra-articular injection of MIA at a dose of 3 mg per rat. The efficacy of intra-articular injections of 10 U BoNT-A and 20 U BoNT-A was assessed through body weight monitoring, knee circumference measurements, leg posture scoring, as well as X-ray, µCT and histopathological examination. Data were analysed using repeated measures ANOVA, generalised linear model, Kruskal-Wallis test, independent samples T test and Mann-Whitney U test. BoNT-A administration led to a significant decrease in body weight and a significant increase in lameness scoring. No significant change was observed in knee circumference measurements by the end of the study. While X-ray evaluations showed no significant differences, micro-CT analyses revealed statistically significant changes. In conclusion, BoNT-A produced statistically significant yet clinically negligible effects on pain and bone parameters. Additionally, higher doses (20U) of BoNT-A were associated with adverse effects.

  • Open Access

    Blood-Derived Products in the Treatment of Corneal Ulcers: Therapeutic Potential of PRP and PRF

    by Ceyda Çakar, Tolga Meriç Dümbek

    Corneal ulcers are among the most critical ophthalmic disorders requiring urgent intervention, as they pose a significant risk of vision loss and ocular integrity disruption. Conventional treatment strategies primarily aim to reduce pain, prevent secondary infections, control collagen degradation, and support epithelial regeneration. Medical therapy, including topical antibiotics, anticollagenase agents, cycloplegics, and analgesics, forms the cornerstone of initial management. However, in cases resistant to standard approaches or associated with delayed healing, biological products have recently emerged as promising adjunctive options. Blood-derived preparations such as autologous serum, platelet-rich plasma (PRP), and platelet-rich fibrin (PRF) have gained increasing attention in both human and veterinary ophthalmology due to their natural biological composition and regenerative potential. Autologous serum contains essential growth factors, vitamins, and antimicrobial components that nourish epithelial cells and support their migration and proliferation. PRP, characterized by its high platelet concentration, delivers a rapid release of growth factors including PDGF, VEGF, IGF, and EGF, thereby stimulating angiogenesis, fibroblast activation, and epithelial repair. In contrast, PRF represents a second-generation product that incorporates platelets and leukocytes within a fibrin matrix, allowing for a slower and more sustained release of bioactive molecules. This unique feature enhances its effectiveness in chronic and deep corneal ulcers. Overall, blood-derived therapies offer safe, accessible, and biologically compatible alternatives or complements to conventional medical and surgical interventions. Although their clinical potential has been demonstrated in various studies, further standardized and controlled trials are required to establish their long-term efficacy and optimize their use in both veterinary and human ophthalmology.

  • Open Access

    Blood-Derived Biological Therapies in the Management of Osteoarthritis

    by Tolga Meriç Dümbek, Osman Bulut

    Osteoarthritis (OA) is a progressive and multifactorial joint disease characterized by cartilage degeneration, subchondral bone remodeling, osteophyte formation, and synovial inflammation. OA is now understood to be a dynamic disease fueled by inflammatory mediators, catabolic enzymes, and cellular death, rather than a straightforward "wear and tear" ailment. These processes affect the synovium, joint capsule, and periarticular tissues in addition to speeding up the breakdown of cartilage, which eventually results in pain, stiffness, and impaired function. Traditional treatment approaches continue to be primarily palliative, providing brief respite without altering the course of the illness. Regenerative methods are becoming more and more popular as viable substitutes for both human and veterinary patients in recent years. Biological products produced from blood, including autologous conditioned serum (ACS), autologous protein solution (APS), platelet-rich plasma (PRP), and platelet-rich fibrin (PRF), have shown promising outcomes. In order to promote chondrocyte activity, extracellular matrix formation, angiogenesis, and mesenchymal stem cell activation, PRP and PRF mainly work by supplying platelets, growth factors, and cytokines. ACS and APS, on the other hand, reduce pain and restore joint homeostasis by targeting inflammatory pathways, namely by regulation of interleukin-1 receptor antagonist (IL-1Ra). According to preclinical and clinical research, these products may help with both structural and symptom alleviation, particularly in cases of early to moderate OA. Notwithstanding encouraging results, variations in product composition, treatment regimens, and preparation techniques restrict standardization and make cross-study comparisons more difficult. Nonetheless, blood-derived products provide OA patients enhanced function and quality of life by combining regeneration potential with symptom control, making them a valuable biological therapy.

  • Open Access

    A Case of Metallic Foreign Body in a Dog's Liver

    by Tolga Meriç Dümbek, Ceyda Çakar, Bülent Ulutaş, Ali Belge

    Foreign body migration into the liver is an extremely rare but potentially life-threatening condition. This case report describes the clinical presentation, diagnosis, surgical treatment and outcome of a metallic foreign body that migrated into the liver of a four-year-old German Shepherd Dog. The patient was initially presented with nonspecific clinical signs, including anorexia, lethargy and weight loss and had a temporary response to antibiotic therapy. Radiographic imaging revealed a metallic object in the cranial abdomen. Following stabilization, surgical removal via laparotomy was performed and the foreign body was extracted from the left lateral hepatic lobe without complications. Despite initial postoperative improvement, the patient died suddenly on the third postoperative day. Due to the owner's refusal of a necropsy, the cause of death could not be determined. This case highlights the diagnostic challenges associated with migrating foreign bodies and emphasizes the critical importance of postoperative monitoring.

  • Open Access

    Regenerative effect of lyophilized dental follicle mesenchymal stem cells and platelet-rich fibrin in skin wounds in geriatric and young rats

    by Osman Bulut, Deniz Genc, Çiğdem Elif Demirci, Leyla Tekin, Tolga Meriç Dümbek, Aziz Bülbül

    The aim of this study was to investigate the regenerative effect of lyophilized dental follicle mesenchymal stem cells (DF-MSCs) combined with rat platelet-rich fibrin (PRF) on geriatric skin wounds. Human DF-MSCs which were isolated from the wisdom teeth of healthy donors and PRF were mixed and incubated in a 37 °C incubator for 1–2 h containing 1 million cells in 150 mg PRF. The mixture was suspended in a freeze-drying solution and then lyophilized. Wounds were created on the back skin of Wistar albino rats using a 6 mm punch. Lyophilized DF-MSCs, PRF, or PRF + DF-MSCs were applied to the wounds of rats. On the 15th day, the wound area was histopathologically evaluated in rats. Blood samples from rats were analyzed for total antioxidant status (TAOS), and inflammatory cytokine levels using ELISA. In both young and geriatric rats treated with lyophilized PRF + DF-MSCs, wound area began to significantly decrease from the 10th day compared to the untreated group (p < 0.05). Histopathological examination revealed that in the lyophilized PRF + DF-MSCs treated groups, epithelial integrity and scarless healing significantly increased compared to the untreated groups (p < 0.05). There were no significant differences in TAOS, total oxidant status (TOS), tumor necrosis factor (TNF), interleukin-6 (IL6), and hydroxyproline levels in serum samples from young rats on the 15th day. In geriatric rats, hydroxyproline (HYPS) levels were increased in the DF-MSC and PRF + DF-MSC groups (p < 0.01), TNF was significantly elevated in PRF geriatric group and IL6 was increased in the PRF group compared to the control group (p = 0.01). Lyophilized PRF + DF-MSCs, which is a shelf-stable and ready-to-use product, hold promise, especially for traumatic wounds in geriatric individuals with longer healing times.